Study Attempts to Create New Beta Cells


By: J. Chanslor

Procter & Gamble Pharmaceuticals is sponsoring a new study on the safety and efficacy of INGAP-peptide.

Researchers are currently recruiting new patients to attempt to create new beta cells in the pancreas and to restore the ability to produce insulin in people with type 1 diabetes.

The phase 2 study is interventional, randomized, double blinded, and placebo controlled.


At present, the type 1 arm of the study is full. However, there is still a need for some type 2s who would like to take part in the study.

Requirements for type 2s who wish to participate are:

  • You must be between 35 and 70 years old
  • You must have an A1C between 6.5% and 10%
  • You must have a fasting C-peptide of less than 0.3 ng/ml

Clinical Trials-National Institutes of Health, November 2003



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.